Stephen Dale Kura Oncology, Inc. (KURA) insider trading activity

KURA Quotes by TradingView

Stephen Dale is Chief Medical Officer of Kura Oncology, Inc.. Currently has a direct ownership of 38,817 shares of KURA, which is worth approximately $770,517. The most recent transaction as insider was on Jan 30, 2024, when has been sold 4,825 shares (Common Stock) at a price of $21.55 per share, resulting in proceeds of $103,978. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 38.8K
0% 3M change
23.59% 12M change
Total Value Held $770,517

STEPHEN DALE Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 30 2024
SELL
Open market or private sale
$103,978 $21.55 p/Share
4,825 Reduced 11.06%
38,817 Common Stock
Jan 29 2024
SELL
Open market or private sale
$127,412 $17.8 p/Share
7,158 Reduced 14.09%
43,642 Common Stock
Feb 16 2023
BUY
Grant, award, or other acquisition
-
23,125 Added 31.28%
50,800 Common Stock
Jan 27 2023
SELL
Open market or private sale
$128,043 $13.88 p/Share
9,225 Reduced 25.0%
27,675 Common Stock
Jan 26 2022
BUY
Grant, award, or other acquisition
-
36,900 Added 50.0%
36,900 Common Stock
SD

Stephen Dale

Chief Medical Officer
San Diego, CA

Track Institutional and Insider Activities on KURA

Follow Kura Oncology, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KURA shares.

Notify only if

Insider Trading

Get notified when an Kura Oncology, Inc. insider buys or sells KURA shares.

Notify only if

News

Receive news related to Kura Oncology, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on KURA